Episode Details

Back to Episodes
Immune Thrombocytopenic Purpura: The Patient Perspective

Immune Thrombocytopenic Purpura: The Patient Perspective

Season 5 Episode 33 Published 1 day, 2 hours ago
Description

In this patient advocate episode, Ms. Barbara Pruitt shares what it's like to live with immune thrombocytopenia (ITP), a condition she has had since age four. Barbara takes us through more than six decades of treatments, from childhood steroids and a splenectomy to today's newer therapies. She describes growing up without meeting anyone else with ITP and the moment a patient organization changed that. She also talks about the everyday adjustments that let her keep traveling, dancing, and enjoying life, and how a hematologist's words can either wound or empower. Hosts Drs. Ronak Mistry and Vivek Patel explore what clinicians can learn from her story, including why quality of life matters as much as lab values. Barbara closes with advice for anyone newly diagnosed.

Key Takeaways:

  1. Treat the diagnosis as an emotional event, not just a clinical one. Barbara reminds physicians to acknowledge the emotional weight of the diagnosis, and connect patients to peer communities and support resources early, especially children and teens. 
  2. Look beyond the platelet count. Barbara's current therapy hasn't raised her count, but less bruising and fewer petechiae make it worth continuing. She urges clinicians not to abandon a therapy over a small fluctuation and encourages listeners to ask about other symptoms of ITP including fatigue, bleeding, and energy, which are often dismissed. Ask about symptoms and function at every visit, and weigh them alongside the number when judging whether a treatment is working. 
  3. Plan the treatment around the patient's life.Consider how treatment options impact our patient’s quality of life. Present all reasonable options with their pros and cons, and think through practical fit, such as injections versus oral drugs and food interactions. Invite questions about activities and alternative therapies, because patients will otherwise go looking on their own. 

For additional ASH resources related to ITP, please consider visiting our ASH Clinical Practice Guidelines on Immune Thrombocytopenia web page.

This episode was supported by Sanofi.

 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us